Journal of Neuroscience and Clinical Neurology

Dr Oral Oncul

PhD

  • Department: Infectious Diseases
  • University: Istanbul University
  • Country: Turkey

Professor Dr. Oral Oncul, MD, PhD is a leading Turkish physician and researcher specializing in infectious diseases, clinical microbiology, microbiota, oncology, and neuroscience. He serves as Professor at Istanbul University, Faculty of Medicine, onco immune genetic Research Group. A graduate of Gulhane Military Medical, he completed his residency in Infectious Diseases & Clinical Microbiology and later joined Istanbul University. Professor Oncul has held prominent academic and administrative positions, including Dean and Vice Rector of Istanbul University, and is a member of TUBA, TUSEB, and the Turkish Higher Education Council. His research focuses on nosocomial infections, antimicrobial resistance, microbiota–brain interactions, and cancer immunology, with more than 120 international publications and several was Internal Mayo Clinic, he integrates microbiology, immunology, and neuroscience to advance nanomedicine and genetic therapies for infectious and oncological diseases, bridging disciplines across medicine and biotechnology.

  1. Professor of Infectious Diseases & Clinical Microbiology, Istanbul University, Faculty of Medicine.

  2. Leader, Oncoimmunogenetic Research Group, focusing on microbiota–brain interactions, immunogenetics, and neuro-oncology.

  3. Vice Rector and Former Dean, Istanbul University, Faculty of Medicine.

  4. Member, Turkish Higher Education Council (YÖK).

  5. Full Member, Turkish Academy of Sciences (TÜBA).

  6. Member, Health Institutes of Türkiye (TÜSEB).

  7. President, Innovative Oncology Association of Türkiye.

  8. Principal Investigator / Coordinator in numerous international and national research projects funded by TÜBİTAK, European Commission, and Turkish Ministry of Health, including studies on antimicrobial resistance, microbiota–neuroscience connections, and nanomedicine-based therapies.

  9. Patent Holder for multiple biomedical innovations, including polymer-based antibody applications, nanobiosensors, and CRISPR-Cas therapeutic models.

  10. International Collaborations with research institutions such as the Mayo Clinic (USA) in the areas of infectious diseases, immunology, and neuroscience.

  11. Member of International Scientific Societies:

    • American Society for Microbiology (ASM)

    • Infectious Diseases Society of America (IDSA)

    • European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

    • Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK)

    • Turkish Innovative Oncology Association

    • Intensive Care Society

  12. Reviewer and Editorial Contributor for multiple international journals in microbiology, immunology, oncology, and neuroscience.

  13. Author of over 120 international peer-reviewed publications, including studies on neuroinfection, cancer immunology, and microbiota–brain interactions.

  • Does Human Leukocyte Antigens Heterozygosity Influence the Gut Microbiota?
  • Does Human Leucocyte Antigens Heterozygosity Influence the Gut Microbiota?
  • In vitro anti-leukemic effect of Wharton’s jelly derived mesenchymal stem cells
  • MICROBIOTA EFFECT ON HODGKIN LYMPHOMA and NON-HODGKIN LYMPHOMA DISEASE, INTERACTION WITH IL17 and IL12
  • Microbiota Effect on Hodgkin Lymphoma and Non-Hodgkin Lymphoma Disease, Interaction with IL-17 and IL-12
  • Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2
  • MICROBIOTA CHANGES IN HODGKIN AND NON-HODGKIN LYMPHOMA TREATMENT: ASSESSMENT WITH IL17 AND IL12 LEVELS
  • Anticancer drug doxorubicin (DOX) loading performance of functionalized polyaniline (PANI) surface with active carbon